A stamp celebrates Giuliani, Italian excellence

An Italian story that began in 1889 in the Antica Farmacia del Lazzaretto in Milan enters national philately. The Ministry of Business and Made in Italy he dedicated to Giuliani an ordinary stamp belonging to the thematic series “The Excellences of the production system and of Made in Italy”, recognizing the company’s contribution to history pharmaceuticalindustrial and entrepreneurial of the country. The stamp, the company explains in a note, “celebrates not only a historic brand, but a family business model that has been able to transform a pharmaceutical laboratory into an international healthcare industrial platform, based on research, quality, therapeutic specialization, direct brand management and development on global markets”.

From the formula ofGiuliani Medicinal Bitterborn in the Antica Farmacia del Lazzaretto, to the current group active in gastroenterology, dermatology, trichology, gynecology and health of the personGiuliani represents an emblematic case of Italian entrepreneurial continuity capable of combining identity, industrial vision and innovation. “This stamp is a source of great pride for us because it recognizes not only an entrepreneurial history of over 130 years, but also Giuliani’s ability to remain faithful to its identity by transforming it into a contemporary industrial project. Our roots are in the Italian pharmaceutical tradition, but our gaze is turned to the future: research, innovation, quality and international growth are the principles that guide our family and the company”, he comments Giammaria Giulianikey shareholder of the Group together with his brother Mario Germano Giuliani.

Origins and development

Founded in Milan in 1889 by Dr. Germano Giuliani, pharmacist and chemist, the company has gone through over a century of Italian history, evolving from a pharmacy-laboratory to a reality structured pharmaceutical. During the twentieth century Giuliani consolidated its industrial profile, developing scientific, productive, regulatory and commercial skills, to the point of building a business model that integrates research, product development, valorisation of proprietary brands, medical-scientific information, control of the pharmacy channel and progressive internationalization.

Recent acquisitions

In recent years, the note explains, Giuliani has accelerated its growth path through an industrial design based on the aggregation of complementary skills. The entrance of Nathura in 2021 it strengthened its presence in nutraceuticals and the gastrointestinal area; the acquisition of Biogen in 2023 it strengthened the dermatological sector; the operation Bailleul Laboratories in 2025 it strengthened the company’s position in the therapeutic areas of greatest interest and above all brought with it a pan-European platform with its own branches in various countries, significantly expanding the Group’s international presence. This growth path will allow the Group to achieve a turnover of approximately 250 million euros in 2026.

The industrial strategy

“These aggregations – adds Giammaria Giuliani – represent a key step in the evolution of Giuliani: from a historic pharmaceutical company to an integrated healthcare group, with an increasingly solid presence in specialized therapeutic areas. Our strategy is to build critical mass in the segments in which we operate, enhance assets with a high scientific content and integrate research skills, medical-scientific marketing and commercial development. We want to further strengthen the relationship with doctors, pharmacists, patients and consumers, leveraging recognized brands, distinctive skills and a continually growing international network”.

The role of the family

In this path, the role of the family remains central: Giammaria Giuliani and Mario Germano Giuliani, representatives of the fourth generation, interpret this continuity as an entrepreneurial and cultural responsibility, as shareholders and custodians of a rare entrepreneurial history. “Seeing Giuliani represented on an Italian state stamp is a recognition that belongs to all generations of the family who contributed to building the company, as well as to those who carry out its development today. It is also an incentive to continue to grow Giuliani as an increasingly competitive Italian group on international markets”, concludes Giammaria Giuliani.